Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Respiratory Medicine|March 1, 2005
Phenotypes of asthma revisited upon the presence of atopyAna Nieves, Antoine Magnan, Stéphanie Boniface, et al.
Presse Medicale (Paris, France : 1983)|December 11, 2007
[Exacerbation in asthma: definitions and immunopathology]Arnaud Cavaillès, Domitille Pinot, Ana Nieves, et al.
BMC Pulmonary Medicine|October 29, 2024
Usefulness of monitoring mycophenolic acid exposure in systemic sclerosis-related interstitial lung disease: a retrospective cohort studyJules Milesi, Emmanuelle Sampol, Audrey Benyamine, et al.
ERJ Open Research|August 23, 2023
Impact of targeted pulmonary arterial hypertension therapies in severe pulmonary hypertension in chronic lung diseasesRomain Naud, Julien Bermudez, Noémie Resseguier, et al.
Respiratory Medicine and Research|October 10, 2025
When to test for myositis antibodies in usual interstitial pneumonia on chest CT?Eliott Guillois, Daniel Bertin, Jules Milesi, et al.
Respirology (Carlton, Vic.)|October 4, 2023
Effect of antifibrotic agents on postoperative complications after lung transplantation for idiopathic pulmonary fibrosisElsa Moncomble, Gaelle Weisenburger, Clément Picard, et al.
Respiratory Medicine and Research|February 13, 2025
Forced vital capacity reduction severity in pulmonary fibrosis and post-lung transplantation outcomesManon Levêque, Julien Bermudez, Ana Nieves, et al.
Transplantation|November 3, 2020
COVID-19 in Lung Transplant RecipientsJonathan Messika, Philippine Eloy, Antoine Roux, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 6, 2020
Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung DiseaseLouis Chauvelot, Delphine Gamondes, Julien Berthiller, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 19, 2022
Chronic lung allograft dysfunction is associated with an early increase of circulating cytotoxic CD4+CD57+ILT2+ T cells, selectively inhibited by the immune check-point HLA-GOlivier Brugière, Domitille Mouren, Julie Trichereau, et al.
Pageof 2